NCT02690025View on ClinicalTrials.gov

A Phase 2 Trial Testing ZP1848 in Patients With SBS

PHASE2CompletedINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

May 31, 2017

Study Completion Date

May 31, 2017

Conditions

Short Bowel Syndrome

Interventions

DRUG

ZP1848

Trial Locations (1)

Unknown

Rigshospitalet, Copenhagen

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

Larix A/S

INDUSTRY

lead

Zealand Pharma

INDUSTRY